3.0
Jan 9, 2024
Recommend
CEO approval
Business Outlook
Pros
Big company without good drugs in the pipeline
Cons
Seems like a different company without Ken Fraiser. Culture is very clickish IT does things the Merck way Not great pay Layoffs attitude about being a big pharma, but no greatness Layoffs on the hush so they dont get bad press EIC plan in Austin - didnt come through for those employees